Clinical Trial Update: Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients [Phase 2]

View source ↗

Summary

A phase 2 trial comparing the levonorgestrel-releasing intrauterine system (LNG-IUS) to depot medroxyprogesterone acetate (DMPA) for pelvic pain in clinically d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Depot-medroxyprogesterone acetate (DMPA) (medroxyprogesterone acetate)
• Levonorgestrel-releasing intrauterine system (LNG-IUS) (Levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Chulalongkorn University | Conditions: Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS | Phase 2 | Status: COMPLETED